首页> 外国专利> IMPROVED CYCLIC CRF ANTAGONISTS IMPROVED CYCLIC CRF ANTAGONISTS

IMPROVED CYCLIC CRF ANTAGONISTS IMPROVED CYCLIC CRF ANTAGONISTS

机译:改进的循环CRF拮抗剂改进的循环CRF拮抗剂

摘要

Improved CRF antagonist peptides have the formula: (cyclo 30-33)DPheHisLeuLeuArgGluVal LeuGluNleAlaArgAlaGluGlnLeu IMAGE LeuNleGluIleIleNH2 wherein R30 is Cys or Glu; R33 is Cys, Lys or Orn; provided that when R30 is Cys, R33 is Cys and when R30 is Glu, R33 is Lys or Orn. The N-terminus may be extended by Asp-Leu-Thr. Lys may be substituted for Arg23 and its side chain connected by a lactam bridge to Glu20 to form a dicyclic peptide. Specific CRF antagonists disclosed include (cyclo 30-33) [D-Phe12, Nle21,38, Glu30, Lys33]rCRF(12-41); (cyclo 30-33) [D-Phe12, Nle21,38, Glu30, Orn33]rCRF(12-41), (cyclo 30-33) [D-Phe12, Nle21,38, Cys30,33]rCRF (12-41) and (bicyclo 20-23,30-33) [D-Phe12, Nle21,38, Lys23,33, Glu30]-rCRF(12-41).
机译:改进的CRF拮抗剂肽具有下式:(环30-33)DPheHisLeuLe​​uArgGluVal LeuGluNleAlaArgAlaGluGlnLeu LeuNleGluIleIleNH2其中R30是Cys或Glu; R33是Cys,Lys或Orn;前提是当R30为Cys时,R33为Cys,而当R30为Glu时,R33为Lys或Orn。 N末端可以延长Asp-Leu-Thr。 Lys可以取代Arg23,其侧链通过内酰胺桥连接到Glu20,形成二环肽。公开的特定CRF拮抗剂包括(环30-33)[D-Phe12,Nle21,38,Glu30,Lys33] rCRF(12-41);和(环30-33)[D-Phe12,Nle21,38,Glu30,Orn33] rCRF(12-41),(环30-33)[D-Phe12,Nle21,38,Cys30,33] rCRF(12-41 )和(双环20-23,30-33)[D-Phe12,Nle21,38,Lys23,33,Glu30] -rCRF(12-41)。

著录项

  • 公开/公告号WO9619499A3

    专利类型

  • 公开/公告日1996-09-19

    原文格式PDF

  • 申请/专利权人 THE SALK INSTITUTE FOR BIOLOGICAL STUDIES;

    申请/专利号WO1995US16261

  • 发明设计人 RIVIER JEAN E. F.;

    申请日1995-12-08

  • 分类号C07K14/695;C07K7/64;C12Q1/00;G01N33/53;

  • 国家 WO

  • 入库时间 2022-08-22 03:48:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号